All In Biotech

Drug Trial Radar · NCT07187466

Behavioral and/or Mirabegron to Treat Urinary Symptoms in Parkinson Disease

Sequential Multiple Assignment Randomized Trial to Treat Urinary Symptoms in Parkinson Disease

Last checked: Nov 20, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 146 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

146

Planned (sponsor's estimate)

Start

Nov 9, 2026

Primary completion

Mar 31, 2030

Study completion Jun 30, 2030

Sponsor

Lead sponsor
VA Office of Research and DevelopmentFederal agency
Sponsor type
Federal agency
First posted
Sep 23, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Sequential
Masking
Single (outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to learn about different treatments for overactive bladder symptoms in Parkinson's Disease. The investigators want to find out if people who do not respond to one treatment (either behavioral or drug treatment) will respond to combined treatment. The investigators also want to find out what factors influence whether someone responds to the treatments.

Conditions

  • Overactive Bladder
  • Parkinson Disease

Interventions

  • mirabegronDrug

    Mirabegron is a beta-3-agonist, which acts upon the noradrenergic system and avoids the cognitive and gastrointestinal side effects of anticholinergic bladder relaxants.

  • Exercise-based behavioral therapyBehavioral

    The exercise-based behavioral therapy is a comprehensive training program administered individually by a trained nurse practitioner interventionist to address urinary incontinence and other lower urinary tract symptoms.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. ICIQ-OABTime frame: baseline, 6-weeks, and 12-weeks

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • Atlanta VA Medical and Rehab Center, Decatur, GA

    Decatur, Georgia · Recruiting

  • Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA

    Philadelphia, Pennsylvania · Not yet recruiting

  • VA Salt Lake City Health Care System, Salt Lake City, UT

    Salt Lake City, Utah · Not yet recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.